PL EN


Preferences help
enabled [disable] Abstract
Number of results
2020 | 147 | 35-44
Article title

Solid phase synthesis of novel 1,3,4-oxadiazole derivatives and evaluation of their antimicrobial activity

Content
Title variants
Languages of publication
EN
Abstracts
EN
A series of 5-(N-Aryl/Arylalkyl)-2-(3-Chclorophenyl)-1,3,4-oxadiazole have been synthesized. The constitution of the products has been delineated by elemental analysis and spectral analyses. All the synthesized compounds were screened for their antibacterial activity against Staphylococcus aureus MTCC-96, Escherichia coli MTCC-443, B. subtilis MTCC-441, P. aeruginosa MTCC-1688, and antifungal activity against Aspergillus niger MTCC-282 and Penicillium SP.at different concentration and compared with standards drugs. The minimum inhibition concentration (MIC) of the compounds was studied by micro broth dilution method.
Year
Volume
147
Pages
35-44
Physical description
Contributors
References
  • [1] Ainswarth, J. Am. Chem. Soc., 87(24), 5800-5801 (1965). https://doi.org/10.1021/ja00952a056
  • [2] Kumar, A., D’Souza, S. S., Nagaraj, S. R. M., Gaonkar, S. L., Salimath, B. P., & Rai, K. L. (2009). Antiangiogenic and antiproliferative effects of substituted-1, 3, 4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1α in Ehrlich ascites tumor cells. Cancer Chemotherapy and Pharmacology, 64(6), 1221-1233. https://doi.org/10.1007/s00280-009-0992-y
  • [3] A. Hetzheim, K. Moeckel, Adv. Heterocyclic Chem. 7, 183-224 (1966). https://doi.org/10.1016/s0065-2725(08)60591-7
  • [4] Maslat, A. O., Abussaud, M., Tashtoush, H., & AL-Talib, M. (2002). Synthesis, antibacterial, antifungal and genotoxic activity of bis-1,3,4-oxadiazole derivatives. Polish Journal of Pharmacology, 54(1), 55-60. https://doi.org/10.1080/02772240410001665490
  • [5] Küçükgüzel, Ş. G., Oruç, E. E., Rollas, S., Şahin, F., & Özbek, A. (2002). Synthesis, characterisation and biological activity of novel 4-thiazolidinones, 1, 3, 4-oxadiazoles and some related compounds. European Journal of Medicinal Chemistry, 37(3), 197-206. https://doi.org/10.1016/s0223-5234(01)01326-5
  • [6] Karad, S. C., Purohit, V. B., Avalani, J. R., Sapariya, N. H., & Raval, D. K. (2016). Design, synthesis, and characterization of a fluoro substituted novel pyrazole nucleus clubbed with 1, 3, 4-oxadiazole scaffolds and their biological applications. RSC Advances, 6(47), 41532-41541. https://doi.org/10.1039/c6ra01349j
  • [7] Rane, R. A., Bangalore, P., Borhade, S. D., & Khandare, P. K. (2013). Synthesis and evaluation of novel 4-nitropyrrole-based 1,3,4-oxadiazole derivatives as antimicrobial and anti-tubercular agents. European Journal of Medicinal Chemistry, 70, 49-58. https://doi.org/10.1016/j.ejmech.2013.09.039
  • [8] Farghaly, A. H. (2004). Synthesis, Reactions and Antimicrobial Activity of Some New Indolyl‐1, 3, 4‐Oxadiazole, Thiazole and Pyrazole Derivatives. Journal of the Chinese Chemical Society, 51(1), 147-156. https://doi.org/10.1002/jccs.200400023
  • [9] Desai, N. C., Bhatt, N. B., Somani, H. C., & Bhatt, K. A. (2016). Synthesis and antimicrobial activity of some thiazole and 1, 3, 4-oxadiazole hybrid heterocycles. Indian Journal of Chemistry, 55, 94-101. https://doi.org/10.1007/s00044-014-1108-8
  • [10] Sangshetti, J. N., Chabukswar, A. R., & Shinde, D. B. (2011). Microwave assisted one pot synthesis of some novel 2, 5-disubstituted 1, 3, 4-oxadiazoles as antifungal agents. Bioorganic & medicinal chemistry letters, 21(1), 444- 448. https://doi.org/10.1016/j.bmcl.2010.10.120
  • [11] Terenzi, A., Fanelli, M., Ambrosi, G., Amatori, S., Fusi, V., Giorgi, L & Barone, G. (2012). DNA binding and antiproliferative activity toward human carcinoma cells of copper (II) and zinc (II) complexes of a 2, 5-diphenyl [1, 3, 4] oxadiazole derivative. Dalton Transactions, 41(15), 4389-4395. https://doi.org/10.1039/c2dt11759b
  • [12] Bhat, K. S., Karthikeyan, M. S., Holla, B. S., & Shetty, N. S. (2004). Synthesis of some new fluorine containing 1, 3, 4-oxadiazole derivatives as potential antibacterial and anticancer agents. Indian J Chem B, 43, 1765-1769. https://doi.org/10.1002/chin.200450090
  • [13] Abdel-Aziz, M., A Metwally, K., Gamal-Eldeen, A. M., & M Aly, O. (2016). 1, 3, 4-oxadiazole-2-thione Derivatives; Novel Approach for Anticancer and Tubulin Polymerization Inhibitory Activities. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents), 16(2), 269-277. https://doi.org/10.2174/1871520615666150907093855
  • [14] Khan, M. T. H., Choudhary, M. I., Khan, K. M., & Rani, M. (2005). Structure–activity relationships of tyrosinase inhibitory combinatorial library of 2, 5-disubstituted-1, 3, 4-oxadiazole analogues. Bioorganic & Medicinal Chemistry, 13(10), 3385-3395.https://doi.org/10.1016/j.bmc.2005.03.012
  • [15] Dolman, S. J., Gosselin, F., O'Shea, P. D., & Davies, I. W. (2006). Superior reactivity of thiosemicarbazides in the synthesis of 2-amino-1, 3, 4-oxadiazoles. The Journal of Organic Chemistry, 71(25), 9548-9551. https://doi.org/10.1021/jo0618730
  • [16] El‐Samii, Z. K. (1992). Synthesis and anti‐inflammatory activity of some novel 1,3,4‐oxadiazole derivatives. Journal of Chemical Technology and Biotechnology, 53(2), 143-146. https://doi.org/10.1002/jctb.280530206
  • [17] Ilango, K., Valentina, P., Kumar, G., Dixit, D., Nilewar, S., & K Kathiravan, M. (2015). Design, Synthesis and QSAR Studies on a Series of 2, 5- Disubstituted-1, 3, 4-oxadiazole Derivatives of Diclofenac and Naproxen for Analgesic and Anti-inflammatory Activity. Medicinal Chemistry, 11(8), 753-763. https://doi.org/10.2174/1573406411666150519112037
  • [18] Akhter, M., Husain, A., Azad, B., & Ajmal, M. (2009). Aroylpropionic acid based 2, 5-disubstituted-1, 3, 4-oxadiazoles: Synthesis and their anti-inflammatory and analgesic activities. European Journal of Medicinal Chemistry, 44(6), 2372-2378. https://doi.org/10.1016/j.ejmech.2008.09.005
  • [19] Johns, B. A., Weatherhead, J. G., Allen, S. H., Thompson, J. B., Garvey, E. P., Foster, S. A., ... & Miller, W. H. (2009). 1, 3, 4-Oxadiazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 2: SAR of the C5 position. Bioorganic & Medicinal Chemistry Letters, 19(6), 1807-1810. https://doi.org/10.1016/j.bmcl.2009.01.089
  • [20] Khatale, P. N., & Sivakumar, T. (2015). Methods of Synthesis of 1,3,4‐Oxadiazole‐2‐thiones: A Review. ChemInform, 46(13). https://doi.org/10.1002/chin.201513324
  • [21] Khalilullah, H., J Ahsan, M., Hedaitullah, M., Khan, S., & Ahmed, B. (2012). 1,3,4-Oxadiazole: A biologically active scaffold. Mini reviews in medicinal chemistry, 12(8), 789-801. https://doi.org/10.2174/138955712801264800
  • [22] Parikh, K., & Joshi, D. (2014). Synthesis and evaluation of 2-(5-(aryl)-1,3,4-oxadiazol-2-ylthio)-N-(3-(trifluoromethyl) phenyl) acetamides and N-(4- chloro-3-fluorophenyl)-2-(5-(aryl)-1, 3, 4-oxadiazol-2-ylthio) acetamides as antimicrobial agents. Journal of Chemical Sciences, 126(3), 827-835. https://doi.org/10.1007/s12039-014-0625-9
  • [23] Hajdok, I., Bona, A., Werner, H. J., & Kerres, J. (2014). Synthesis and characterization of fluorinated and sulfonated poly (arylene ether-1, 3, 4- oxadiazole) derivatives and their blend membranes. European Polymer Journal, 52, 76-87. https://doi.org/10.1016/j.eurpolymj.2013.12.003
  • [24] National committee for clinical laboratory standards. (M7A5), 5th ed.; NCCLS: Wayne, PA, (2000). https://doi.org/10.1093/clinchem/34.8.1665
  • [25] Patel, N.B.; Shaikh, A.R. Indian J. Chem. 49B, 929-936 (2010). https://doi.org/10.4103/0970-0218.62571
  • [26] Rattan, A. Antimicrobial in laboratory medicine; BI Churchill Livingstone: India, p. 85, (2000). https://doi.org/10.1111/j.1365-2257.1985.tb00041.x
Document Type
article
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-8c3a7084-818f-480a-bd1f-e6abeb18efea
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.